The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $7.67 per gram over the past year.
Market view
olopatadine hydrochloride and mometasone furoate
4 marketed package NDCs · 2 active manufacturers
Most dispensed: 665 ug; MONOHYDRATE 25 ug · Spray, Metered · #12 cartons/box / 1 bottle, spray in 1 carton / 240 spray, metered in 1 bottle, spray
Price range and competition
RSS: changes for this drugEvery company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $7.67 · middle half $7.67–$7.67 · full range $7.67–$7.67 · 2 products · 2 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for olopatadine hydrochloride and mometasone furoate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- RyaltrisSep 2, 2026Mfr exitedHikma Specialty Usa Inc. · olopatadine hydrochloride and mometasone furoate
- RyaltrisSep 2, 2026Mfr exitedGlenmark Pharmaceuticals Inc., USA · olopatadine hydrochloride and mometasone furoate
- RyaltrisAug 26, 2026Mfr enteredHikma Specialty Usa Inc. · olopatadine hydrochloride and mometasone furoate
- RyaltrisAug 26, 2026Mfr enteredGlenmark Pharmaceuticals Inc., USA · olopatadine hydrochloride and mometasone furoate
- RyaltrisJul 29, 2026Mfr exitedHikma Specialty Usa Inc. · olopatadine hydrochloride and mometasone furoate
- RyaltrisJul 29, 2026Mfr exitedGlenmark Pharmaceuticals Inc., USA · olopatadine hydrochloride and mometasone furoate
- RyaltrisJul 22, 2026Price upNADAC $7.66836 → $7.67149 per unit (+0.04%)
- RyaltrisJul 22, 2026Price upNADAC $7.66836 → $7.67149 per unit (+0.04%)
- RyaltrisJul 22, 2026Mfr enteredHikma Specialty Usa Inc. · olopatadine hydrochloride and mometasone furoate
- RyaltrisJul 22, 2026Mfr enteredGlenmark Pharmaceuticals Inc., USA · olopatadine hydrochloride and mometasone furoate
Same drug class
Other molecules FDA puts in Histamine-1 Receptor Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Olopatadine hydrochloride and mometasone furoate in shortage right now?
- No. FDA does not currently list Olopatadine hydrochloride and mometasone furoate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Olopatadine hydrochloride and mometasone furoate?
- 2 companies have marketed Olopatadine hydrochloride and mometasone furoate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Olopatadine hydrochloride and mometasone furoate cost?
- The typical pharmacy pays about $7.67 per gram, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.